Cowen & Co. Initiates Coverage On Nautilus Biotechnology with Outperform Rating

Cowen & Co. analyst Max Masucci initiates coverage on Nautilus Biotechnology (NASDAQ:NAUT) with a Outperform rating.

Cowen & Co. analyst Max Masucci initiates coverage on Nautilus Biotechnology (NASDAQ:NAUT) with a Outperform rating.

Total
0
Shares
Related Posts
Read More

EXCLUSIVE: Unrivaled Brands To Acquire People’s First Choice In $60M Deal, Expands California Cannabis Retail Footprint

Unrivaled Brands, Inc., (OTCQX: UNRV), a multi-state cannabis company, on Monday said it has executed a definitive agreement to acquire People’s First Choice, which operates an existing dispensary in Santa Ana, California, and has licenses or license applications for three additional locations wit

UNRV